Browsing by Author "K. Aggarwal"

Now showing 1 - 1 of 1

Indian National Association for the Study of the Liver—Federation of Obstetric and Gynaecological Societies of India Position Statement on Management of Liver Diseases in Pregnancy
(Elsevier B.V., 2019) Anil Arora; Ashish Kumar; Anil C. Anand; Pankaj Puri; Radha K. Dhiman; Subrat K. Acharya; K. Aggarwal; Neelam Aggarwal; Rakesh Aggarwal; Yogesh K. Chawla; Vinod K. Dixit; Ajay Duseja; Chundamannil E. Eapen; Bhabadev Goswami; Kanwal Gujral; A. Gupta; A. Jindal; Premashish Kar; Krishna Kumari; Kaushal Madan; Jaideep Malhotra; Narendra Malhotra; Gaurav Pandey; Uma Pandey; Ratna D. Puri; Ramesh R. Rai; Padaki N. Rao; Shiv K. Sarin; Aparna Sharma; Praveen Sharma; Koticherry T. Shenoy; Karam R. Singh; Shivaram P. Singh; Vanita Suri; Nirupama Trehanpati; M. Wadhawan
Liver diseases occurring during pregnancy can be serious and can progress rapidly, affecting outcomes for both the mother and fetus. They are a common cause of concern to an obstetrician and an important reason for referral to a hepatologist, gastroenterologist, or physician. Liver diseases during pregnancy can be divided into disorders unique to pregnancy, those coincidental with pregnancy, and preexisting liver diseases exacerbated by pregnancy. A rapid differential diagnosis between liver diseases related or unrelated to pregnancy is required so that specialist and urgent management of these conditions can be carried out. Specific Indian guidelines for the management of these patients are lacking. The Indian National Association for the Study of the Liver (INASL) in association with the Federation of Obstetric and Gynaecological Societies of India (FOGSI) had set up a taskforce for development of consensus guidelines for management of patients with liver diseases during pregnancy, relevant to India. For development of these guidelines, a two-day roundtable meeting was held on 26–27 May 2018 in New Delhi, to discuss, debate, and finalize the consensus statements. Only those statements that were unanimously approved by most members of the taskforce were accepted. The primary objective of this review is to present the consensus statements approved jointly by the INASL and FOGSI for diagnosing and managing pregnant women with liver diseases. This article provides an overview of liver diseases occurring in pregnancy, an update on the key mechanisms involved in its pathogenesis, and the recommended treatment options. © 2019